Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results

<p>Topline data results from the pivotal STRIDE study are expected in December 2023 IRVINE, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, today reported financial results for the third quarter ended September […]</p>
<p>The post <a href="https://forextv.com/top-news/reneo-pharmaceuticals-reports-third-quarter-2023-financial-results/">Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>